← Open Payments lookup

JERRICK PADILLA-PHU: Open Payments

NPI 1457976938 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,970 in 173 payments from 45 companies in 2025. Trend: 2023 $4,512 · 2024 $4,049 · 2025 $4,970

Food & beverage: $3,970Long term medical supply or device loan: $1,000
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation21$1,182
PFIZER INC.11$268
Eisai Inc.11$230
Merck Sharp & Dohme LLC7$219
Janssen Biotech, Inc.10$200
GlaxoSmithKline, LLC.7$192
Genentech USA, Inc.8$188
E.R. Squibb & Sons, L.L.C.9$167
Lilly USA, LLC7$164
Takeda Pharmaceuticals U.S.A., Inc.6$144

Products named: KISQALI, Lenvima, OJJAARA, KEYTRUDA, Venclexta, VERZENIO, TIVDAK, Enhertu.

Industry payments across CA — which companies pay providers there.